{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP01479",
    "Peptide Name": "Adrenomedullin (AM; ADM; neuropeptide; hypotensitve peptide; 1S=S; UCSS1a; natural AMPs; human; primates, mammals, animals; XXA)",
    "Source": "adrenal medulla, skin, oral/saliva;Homo sapiens",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY",
    "Sequence Length": 52,
    "UniProt Entry": "",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "2L7S",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 2.6,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "28%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "History: Adrenomedullin was initially identified to exhibit vasodilatory and hypotensive effects and participate in blood pressure control (Perret M et al., 1993;Kitamura K et al., 1993). There is a disulfide bond between residues 16 and 21. In 1999, it is established as a potent AMP (see the ref).Activity:Active against skin isolates P. acnes, S. aureus (zone size 4), M. luteus, oral cavity pathogens P. gingivalis ATCC 33277, P. gingivalis W50, E. corrodens, A. actinomycetemcomitans, A. naeslundii, S. mutans, Respiratory tract pathogens S. pneumoniae, S. pyogenes,  H. in£uenzae, gut pathogens B. fragilis (zone size 1), E. coli,   and H. pylori (zone size 1-25, unspecified over zone size 10). Highly active against P. acnes and P. gingivalis ATCC 33277 (MBC 0.003 ug/ml).  The C-terminal region is more antimicrobial (Allaker et al 2006 Peptides 27: 661-666).  Chemokine respone can not be predicted based on antibacterial activity (Mediators Inflamm. 2007;2007:30987).Structure:Perez-Castells J et al (2011) reported 3D structure determination in micelles (Pérez-Castells J et al., 2012). Only the central one third is helical.You can rotate, zoom, and view the 3D structureherein the PDB.  Updated 8/2011; 6/2016 GW.",
    "Author": "Allaker RP, Zihni C, Kapas S.1999",
    "Reference": "FEMS Immunol Med Microbiol. 1999 Apr;23(4):289-93.PubMed.GenBank:AAB26458.1",
    "Title": "An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora"
  },
  "3D Structure": []
}